Home › Trial NCT01233843
Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.
- Trial IDNCT01233843
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorGroupe Oncologie Radiotherapie Tete et Cou
- Enrollment370
- Start date2009-05-18
- ConditionsSquamous Cell Head and Neck Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.